NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Further research into the specific mechanisms of action and effects of these compounds on NRF2 activation and downstream pathways, as well as validation in in vivo studies and pharmacokinetic evaluations, will be essential to fully explore their therapeutic potential for NAFLD and other oxidative stress-related diseases.